Authors
Loading...
Treatment lowers blood sugar in type I diabetes, suggesting PLGA nanoparticles may improve autoimmune disease outcomes.
Cogswell et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: